Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Camerlo

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
British Journal of Cancer|January 1, 1997
Discordance between physicians' estimations and breast cancer patients' self-assessment of side-effects of chemotherapy: an issue for quality of careG Macquart-Moulin, P Viens, M L Bouscary, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1986
Treatment of malignant lymphoma with high dose of chemo or chemoradiotherapy and bone marrow transplantationB Mascret, D Maraninchi, J A Gastaut, et al.
Cancer|May 18, 1999
Concomitant chemoradiotherapy for patients with nonmetastatic breast carcinoma: side effects, quality of life, and organizationG Macquart-Moulin, P Viens, D Genre, et al.
Pathologie-Biologie|September 1, 1988
[Bacteremias after bone marrow grafts in a protected environment: effects, various aspects and prognosis]G Michel, D Maraninchi, D Blaise, et al.
Bone Marrow Transplantation|August 1, 1991
Prevention of acute GVHD by in vivo use of anti-interleukin-2 receptor monoclonal antibody (33B3.1): a feasibility trial in 15 patientsD Blaise, D Olive, M Hirn, et al.
Anticancer Research|June 9, 2001
Phase II study of a combination of cisplatin, all-trans-retinoic acid and interferon-alpha in squamous cell carcinoma: clinical results and pharmacokineticsA Goncalves, J Camerlo, H Bun, et al.
European Cytokine Network|September 1, 1996
Impact of recombinant human granulocyte colony stimulating factor on dose intensity and toxicity of three cycles of methotrexate, vinblastine, doxorubicin and cisplatin in patients with previously untreated urothelial bladder carcinomaP Viens, G Gravis, F Bladou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2000
Patient participation in medical decision-making: a French study in adjuvant radio-chemotherapy for early breast cancerC Protière, P Viens, D Genre, et al.
European Journal of Nuclear Medicine|October 31, 2001
Hodgkin's disease: prognostic role of gallium scintigraphy after chemotherapyI Brenot-Rossi, R Bouabdallah, D Di Stefano, et al.
Bone Marrow Transplantation|November 1, 1994
Delayed administration of granulocyte colony-stimulating factor after autologous bone marrow transplantation: effect on granulocyte recoveryN Vey, S Molnar, C Faucher, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
British Journal of Cancer|January 1, 1997
Discordance between physicians' estimations and breast cancer patients' self-assessment of side-effects of chemotherapy: an issue for quality of careG Macquart-Moulin, P Viens, M L Bouscary, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1986
Treatment of malignant lymphoma with high dose of chemo or chemoradiotherapy and bone marrow transplantationB Mascret, D Maraninchi, J A Gastaut, et al.
Cancer|May 18, 1999
Concomitant chemoradiotherapy for patients with nonmetastatic breast carcinoma: side effects, quality of life, and organizationG Macquart-Moulin, P Viens, D Genre, et al.
Pathologie-Biologie|September 1, 1988
[Bacteremias after bone marrow grafts in a protected environment: effects, various aspects and prognosis]G Michel, D Maraninchi, D Blaise, et al.
Bone Marrow Transplantation|August 1, 1991
Prevention of acute GVHD by in vivo use of anti-interleukin-2 receptor monoclonal antibody (33B3.1): a feasibility trial in 15 patientsD Blaise, D Olive, M Hirn, et al.
Anticancer Research|June 9, 2001
Phase II study of a combination of cisplatin, all-trans-retinoic acid and interferon-alpha in squamous cell carcinoma: clinical results and pharmacokineticsA Goncalves, J Camerlo, H Bun, et al.
European Cytokine Network|September 1, 1996
Impact of recombinant human granulocyte colony stimulating factor on dose intensity and toxicity of three cycles of methotrexate, vinblastine, doxorubicin and cisplatin in patients with previously untreated urothelial bladder carcinomaP Viens, G Gravis, F Bladou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2000
Patient participation in medical decision-making: a French study in adjuvant radio-chemotherapy for early breast cancerC Protière, P Viens, D Genre, et al.
European Journal of Nuclear Medicine|October 31, 2001
Hodgkin's disease: prognostic role of gallium scintigraphy after chemotherapyI Brenot-Rossi, R Bouabdallah, D Di Stefano, et al.
Bone Marrow Transplantation|November 1, 1994
Delayed administration of granulocyte colony-stimulating factor after autologous bone marrow transplantation: effect on granulocyte recoveryN Vey, S Molnar, C Faucher, et al.
Pageof 5